Menu
Back to Journals » Substance Abuse and Rehabilitation » Volume 3 » Issue 1
Letter to the editor
Authors Newman RG
Received 2 February 2012
Accepted for publication 2 February 2012
Published 14 March 2012 Volume 2012:3(1) Pages 9—10
Robert G Newman
Baron Edmond de Rothschild Chemical, Dependency Institute of Beth Israel Medical Center, New York, NY, USA
In response to "Privacy protection for patients with substance use problems", there is indeed a compelling reason to worry about loosening of the Federal confidentiality regulation, 42 CFR Part 2, which requires special protection for patient information maintained by addiction treatment facilities. This concern is not so much based on fear of misuse and/or unauthorized further disclosure by the recipient of such information.
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.